Novel and potent antimicrobial effects of caspofungin on drug-resistant Candida and bacteria

[1]  H. Okudera,et al.  Characteristics and outcomes of bacteremia among ICU-admitted patients with severe sepsis , 2020, Scientific Reports.

[2]  Brendan R. Jackson,et al.  Population-Based Active Surveillance for Culture-Confirmed Candidemia — Four Sites, United States, 2012–2016 , 2019, Morbidity and mortality weekly report. Surveillance summaries.

[3]  Jun Zhang,et al.  Ethanol locks for the prevention of catheter-related infection in patients with central venous catheter: A systematic review and meta-analysis of randomized controlled trials , 2019, PloS one.

[4]  Fengqi Sun,et al.  Hypoionic Shock Facilitates Aminoglycoside Killing of Both Nutrient Shift- and Starvation-Induced Bacterial Persister Cells by Rapidly Enhancing Aminoglycoside Uptake , 2019, Front. Microbiol..

[5]  S. Lone,et al.  Candida auris—the growing menace to global health , 2019, Mycoses.

[6]  Shruthi Satish,et al.  Stress-Induced Changes in the Lipid Microenvironment of β-(1,3)-d-Glucan Synthase Cause Clinically Important Echinocandin Resistance in Aspergillus fumigatus , 2019, mBio.

[7]  D. Perlin,et al.  Fungal Resistance to Echinocandins and the MDR Phenomenon in Candida glabrata , 2018, Journal of fungi.

[8]  R. Price,et al.  UCT943, a Next-Generation Plasmodium falciparum PI4K Inhibitor Preclinical Candidate for the Treatment of Malaria , 2018, Antimicrobial Agents and Chemotherapy.

[9]  M. Ghannoum,et al.  Methodologies for in vitro and in vivo evaluation of efficacy of antifungal and antibiofilm agents and surface coatings against fungal biofilms , 2018, Microbial cell.

[10]  B. Kullberg,et al.  Invasive Candidiasis. , 2019, The New England journal of medicine.

[11]  M. Selsted,et al.  Fungicidal Potency and Mechanisms of θ-Defensins against Multidrug-Resistant Candida Species , 2018, Antimicrobial Agents and Chemotherapy.

[12]  B. Rammaert,et al.  What Could Be the Role of Antifungal Lock-Solutions? From Bench to Bedside , 2018, Pathogens.

[13]  S. Majumdar,et al.  Echinocandins in antifungal pharmacotherapy , 2017, The Journal of pharmacy and pharmacology.

[14]  Alexander D. Johnson,et al.  Development and regulation of single- and multi-species Candida albicans biofilms , 2017, Nature Reviews Microbiology.

[15]  Thomas J. Walsh,et al.  Novel Agents and Drug Targets to Meet the Challenges of Resistant Fungi. , 2017, The Journal of infectious diseases.

[16]  A. Borman,et al.  Isolates of the emerging pathogen Candida auris present in the UK have several geographic origins. , 2017, Medical mycology.

[17]  J. Argüelles,et al.  ROS formation is a differential contributory factor to the fungicidal action of Amphotericin B and Micafungin in Candida albicans. , 2017, International journal of medical microbiology : IJMM.

[18]  Hironobu Nakayama,et al.  Roles of vacuolar H+-ATPase in the oxidative stress response of Candida glabrata. , 2016, FEMS yeast research.

[19]  A. Afshari,et al.  Central venous catheter (CVC) removal for patients of all ages with candidaemia. , 2016, The Cochrane database of systematic reviews.

[20]  S. Ranque,et al.  Environmental distribution of Cryptococcus neoformans and C. gattii around the Mediterranean basin. , 2016, FEMS yeast research.

[21]  D. Perlin.  Echinocandin Resistance in Candida. , 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[22]  T. Walsh,et al.  Role of Echinocandins in Fungal Biofilm-Related Disease: Vascular Catheter-Related Infections, Immunomodulation, and Mucosal Surfaces. , 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[23]  Xinmiao Fu,et al.  Hypoionic shock treatment enables aminoglycosides antibiotics to eradicate bacterial persisters , 2015, Scientific Reports.

[24]  D. Perlin.  Mechanisms of echinocandin antifungal drug resistance , 2015, Annals of the New York Academy of Sciences.

[25]  P. Sanitá,et al.  Dynamics of Biofilm Formation and the Interaction between Candida albicans and Methicillin-Susceptible (MSSA) and -Resistant Staphylococcus aureus (MRSA) , 2015, PloS one.

[26]  T. Beißbarth,et al.  Primary bacteraemia is associated with a higher mortality risk compared with pulmonary and intra-abdominal infections in patients with sepsis: a prospective observational cohort study , 2015, BMJ Open.

[27]  Anita Driessen-Mol,et al.  How to make a heart valve: from embryonic development to bioengineering of living valve substitutes. , 2014, Cold Spring Harbor perspectives in medicine.

[28]  L. Mermel,et al.  Adverse effects associated with ethanol catheter lock solutions: a systematic review. , 2014, The Journal of antimicrobial chemotherapy.

[29]  J. Argüelles,et al.  The Production of Reactive Oxygen Species Is a Universal Action Mechanism of Amphotericin B against Pathogenic Yeasts and Contributes to the Fungicidal Effect of This Drug , 2014, Antimicrobial Agents and Chemotherapy.

[30]  T. Walsh,et al.  Caspofungin at Catheter Lock Concentrations Eradicates Mature Biofilms of Candida lusitaniae and Candida guilliermondii , 2014, Antimicrobial Agents and Chemotherapy.

[31]  T. Roemer,et al.  Antifungal drug development: challenges, unmet clinical needs, and new approaches. , 2014, Cold Spring Harbor perspectives in medicine.

[32]  B. Peters,et al.  Candida albicans-Staphylococcus aureus Polymicrobial Peritonitis Modulates Host Innate Immunity , 2013, Infection and Immunity.

[33]  David W. Denning,et al.  Hidden Killers: Human Fungal Infections , 2012, Science Translational Medicine.

[34]  Samuel A. Lee,et al.  Antifungal Lock Therapy , 2012, Antimicrobial Agents and Chemotherapy.

[35]  G. Fadda,et al.  Risk Factors and Outcomes of Candidemia Caused by Biofilm-Forming Isolates in a Tertiary Care Hospital , 2012, PloS one.

[36]  E. Mohammadi,et al.  Barriers and facilitators related to the implementation of a physiological track and trigger system: A systematic review of the qualitative evidence , 2017, International journal for quality in health care : journal of the International Society for Quality in Health Care.

[37]  S. Samarghandian,et al.  Use of in vitro assays to assess the potential antiproliferative and cytotoxic effects of saffron (Crocus sativus L.) in human lung cancer cell line , 2010, Pharmacognosy magazine.

[38]  David W Williams,et al.  Biofilms of non-Candida albicans Candida species: quantification, structure and matrix composition. , 2009, Medical mycology.

[39]  B. Souweine,et al.  Eradication of microorganisms embedded in biofilm by an ethanol-based catheter lock solution. , 2009, Nephrology, Dialysis and Transplantation.

[40]  M. Harriott,et al.  Candida albicans and Staphylococcus aureus Form Polymicrobial Biofilms: Effects on Antimicrobial Resistance , 2009, Antimicrobial Agents and Chemotherapy.

[41]  L. Vercaigne,et al.  Effectiveness of a 30% ethanol/4% trisodium citrate locking solution in preventing biofilm formation by organisms causing haemodialysis catheter-related infections. , 2008, The Journal of antimicrobial chemotherapy.

[42]  D. Murray,et al.  Treatment of central venous catheter fungal infection using liposomal amphotericin-B lock therapy. , 2008, The Pediatric infectious disease journal.

[43]  J. Lopez-Ribot,et al.  A simple and reproducible 96-well plate-based method for the formation of fungal biofilms and its application to antifungal susceptibility testing. , 2008, Nature protocols.

[44]  W. Bubb,et al.  Antifungal Effects on Metabolite Profiles of Medically Important Yeast Species Measured by Nuclear Magnetic Resonance Spectroscopy , 2006, Antimicrobial Agents and Chemotherapy.

[45]  Matthew P Jacobson,et al.  Testing the conformational hypothesis of passive membrane permeability using synthetic cyclic peptide diastereomers. , 2006, Journal of the American Chemical Society.

[46]  J. Micklefield,et al.  NMR structure determination and calcium binding effects of lipopeptide antibiotic daptomycin. , 2004, Organic & biomolecular chemistry.

[47]  R. Schwartz,et al.  Discovery of Novel Antifungal (1,3)-β-d-Glucan Synthase Inhibitors , 2000, Antimicrobial Agents and Chemotherapy.

[48]  Russell E. Lewis,et al.  Influence of Test Conditions on Antifungal Time-Kill Curve Results: Proposal for Standardized Methods , 1998, Antimicrobial Agents and Chemotherapy.

[49]  Guangyou Duan,et al.  A prospective observational cohort study , 2016 .

[50]  B. Kullberg,et al.  Invasive Candidiasis. , 2015, The New England journal of medicine.

[51]  B. Cammue,et al.  Reactive oxygen species-inducing antifungal agents and their activity against fungal biofilms. , 2014, Future medicinal chemistry.

[52]  D. Perlin,et al.  Evaluation of fungal-specific fluorescent labeled echinocandin probes as diagnostic adjuncts. , 2013, Medical mycology.

[53]  I. Harris,et al.  A Systematic Review and Meta-Analysis of Randomized Controlled Trials , 2010 .

[54]  J. Lopez-Ribot,et al.  A simple and reproducible 96-well plate-based method for the formation of fungal biofilms and its application to antifungal susceptibility testing , 2008, Nature Protocols.

[55]  C. d’Enfert,et al.  Human Fungal Infections. , 1951, British medical journal.